2015 Forty Under 40: Dr. Gaurav Arora
Dr. Gaurav Arora, 39, is chief medical officer for Indiana University Health Saxony Hospital in Fishers.
Health Care
Articles
IU Health to cut 96 workers in Martinsville
In a cost-cutting move, Indiana University Health plans to lay off nearly 100 workers as Morgan Hospital stops admitting overnight patients April 1.
Novartis expects price war with Lilly over psoriasis drugs
Novartis AG is racing to establish itself in the market for new treatments for psoriasis ahead of competing drugs by Amgen Inc. and Eli Lilly and Co. in the United States.
Democrats, hospital group cheer Healthy Indiana Plan ruling
The top Democrat in the Indiana Senate is applauding the federal approval of Gov. Mike Pence's proposal for expansion of the Healthy Indiana Plan.
UPDATE: Healthy Indiana Plan 2.0 gets federal approval
Federal officials have approved Indiana Gov. Mike Pence’s plan to provide health insurance to lower-income Hoosiers, despite provisions that require some participants to pay part of the premium.
Meth bills mandating cold-pill prescriptions face tough road
Bills aiming to reduce Indiana’s methamphetamine problem by requiring prescriptions for some cold medicines probably won’t be considered in House or Senate committees this session, key lawmakers said.
CVS to close local nutrition center with 124 workers
A division of CVS Pharmacy Inc. said it would consolidate work done at the facility to locations in Littleton, Colorado, and Jackson, Tennessee.
Obamacare fees for uninsured kick in with 2014 taxes
Roughly 4 million uninsured people are expected to pay penalties, and 26 million could qualify for exemptions from a list of more than 30 waivers.
IU Health pondering new hospital in Bloomington
Indiana University Health officials are working on plans for building a new hospital in Bloomington to replace the system's aging facility.
Carmel heart surgeon-turned-land developer dies at 81
Pioneering heart surgeon John N. Pittman, a Carmel resident who helped establish the cardiovascular program at Indianapolis’ Methodist Hospital, died on Christmas Day. He was 81.
IU Health prepares to close at least 1 downtown hospital
IU Health wants to consolidate its University and Methodist hospitals into one downtown location, a plan that would see one or both facilities close or be converted to another use.
Homegrown app eases Alzheimer’s care-giving learning curve
Ashley Bryan is on the cusp of launching a website and smartphone application she hopes will ease the learning curve for millions of care givers. It’s called Life in the Moment and it’s billed as a one-stop source for information and tools for managing Alzheimer’s.
Indiana again ranks 41st in U.S. health survey
While the state was strong with regards to immunizations, infectious diseases and binge drinking, it still has work to do in physical activity, obesity, and air pollution.
Zimmer to pay Stryker $70M in surgical device fight
The award is actually less than a third of what Warsaw-based Zimmer was originally ordered to pay for infringing patents on a lavage device.
Lilly reaches insulin development deal with Adocia
Eli Lilly and Co. could pay more than $570 million to French pharmaceutical company Adocia under an agreement to develop a fast-acting insulin that is in the early stages of clinical testing.
Nursing home construction moratorium fight fuels lobbying, donations
The two sides duking it out over a construction ban on nursing homes spent more than $475,000 over six months to win lawmakers to their sides—a spike of 37 percent over previous years. And that kind of high-stakes fight is about to happen again.
Pence: HIP 2.0 timeline not as important as approval
The state and federal government have been in negotiations since the summer, but the governor said he remains confident that an agreement will be reached, even if it isn’t by his original deadline.
Lilly bumps up dividend for first time since 2009
Shares of Eli Lilly and Co. were on the rise Tuesday morning, a day after the drugmaker announced its first dividend increase in more than five years.
Lilly’s Cyramza gets new marketing approval
Eli Lilly and Co.'s drug Cyramza has been approved as a treatment for lung cancer, regulators said. The Food and Drug Administration is allowing Lilly to market the drug as a treatment for cases that have spread.
Alzheimer’s tests present dilemma of knowing the future
While the tests will likely help drug companies like Eli Lilly and Co. evaluate medicines, they’ll also create wrenching personal and ethical dilemmas for patients who will have to live with the knowledge that they’re destined to develop the disease.